MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ymgmr.2026.101293

Медицинская библиотека · Molecular genetics and metabolism reports · 2026

Olipudase alfa treatment for pediatric acid sphingomyelinase deficiency in Egypt: A prospective, observational cohort study with an interventional subgroup.

Arafa Nehal Abdelaziz, Mahfouz Aml, Anwar Shimaa, Marzouk Iman

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

To present key features of pediatric acid sphingomyelinase deficiency (ASMD) and assess the clinical and safety outcomes of enzyme replacement therapy with olipudase alfa.

STUDY

DESIGN

A prospective, observational cohort study of pediatric patients with ASMD that included an interventional subgroup treated with olipudase alfa. Patients presenting to the Alexandria University Children's Hospital in Egypt from June 2022 to May 2023 underwent clinical examination and genetic testing. Clinical and safety outcomes were assessed in patients who received biweekly infusions of olipudase alfa for 12 months.

RESULTS

Fifteen pediatric patients with ASMD were included (10 were classified as type A or A/B and 5 were classified as type B). Patients with ASMD type A or A/B presented earlier and more severely, with a higher rate of mortality than patients with type B. Qualitative improvements in developmental and neurocognitive outcomes, clinical presentation, and laboratory parameters were observed among the patients with ASMD type A/B or type B treated with olipudase alfa (n = 6), with only mild safety events recorded. Treated patients with type B (n = 4) demonstrated significantly improved weight (p = 0.031, η 2 = 0.757) and height/length Z-scores (p = 0.009, η 2 = 0.707), and liver size (p = 0.025, η 2 = 0.839) compared with baseline.

CONCLUSIONS

This case series contributes to the clinical and biochemical understanding of ASMD and may help reduce diagnostic delays and improve clinical management. Olipudase alfa was generally well tolerated, and promising clinical improvements were observed.

Для цитирования: Arafa Nehal Abdelaziz, Mahfouz Aml, Anwar Shimaa, Marzouk Iman. Olipudase alfa treatment for pediatric acid sphingomyelinase deficiency in Egypt: A prospective, observational cohort study with an interventional subgroup.. Molecular genetics and metabolism reports. 2026. DOI: 10.1016/j.ymgmr.2026.101293.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.